{"meta":{"query_hash":"638044ed6f14","filters":{"venue":"Journal of Pharmaceutical Investigation"},"cohort_total":6,"direct_labels_cover":0,"predictions_cover":6,"exported":6,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/638044ed6f14","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Pharmaceutical+Investigation"},"results":[{"id":"W2041109526","doi":"10.1007/s40005-014-0142-3","title":"A rapid and selective LC–MS/MS method for the quantification of aripiprazole in beagle dog plasma and its application to a pharmacokinetic study","year":2014,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Aripiprazole; Chromatography; Chemistry; Beagle; Pharmacokinetics; Selected reaction monitoring; Electrospray ionization; Analyte; Mass spectrometry; Tandem mass spectrometry; Pharmacology; Medicine","score_opus":0.09729894129431453,"score_gpt":0.4388420423838734,"score_spread":0.3415431010895589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041109526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73039526,0.00075472967,0.2637291,0.0034764775,0.00012708052,0.0012368159,0.000013748378,0.000020044256,0.00024674548],"genre_scores_gemma":[0.97148436,0.0001687167,0.027497573,0.00045132186,0.0002310624,0.000119033575,0.0000021165117,0.000025978765,0.000019815794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738705,0.0004754673,0.0011038876,0.00034539273,0.00042186398,0.00026634955],"domain_scores_gemma":[0.9946461,0.0038194356,0.0005619545,0.00017231969,0.0004403654,0.00035986834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045307837,0.00021387494,0.00045520277,0.00020075153,0.00010089854,0.000041606792,0.00026248116,0.000115129325,0.000045114164],"category_scores_gemma":[0.002930238,0.00016606624,0.00007642804,0.00046683723,0.00016897381,0.00019769913,0.00007861409,0.00055918423,0.0000018288758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054161873,0.00033511783,0.003317388,0.0002704721,0.0001750791,0.0000010564017,0.0010230611,0.0013837279,0.88302493,0.0030502349,0.0000825889,0.10679475],"study_design_scores_gemma":[0.0020714086,0.0001996219,0.002223845,0.000054705113,0.0004559888,0.000025000725,0.00017244599,0.4713805,0.5170753,0.0032541538,0.0029505612,0.00013645686],"about_ca_topic_score_codex":0.000010614666,"about_ca_topic_score_gemma":0.0000031936042,"teacher_disagreement_score":0.46999678,"about_ca_system_score_codex":0.00008392019,"about_ca_system_score_gemma":0.000060666407,"threshold_uncertainty_score":0.67719847},"labels":[],"label_agreement":null},{"id":"W2605780223","doi":"10.1007/s40005-017-0327-7","title":"Evaluation of a microemulsion-based gel formulation for topical drug delivery of diclofenac sodium","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Taibah University; University of Alberta","keywords":"Diclofenac Sodium; Microemulsion; Chemistry; Chromatography; Solubility; Zeta potential; Diclofenac; Drug delivery; Viscosity; Penetration (warfare); Pulmonary surfactant; Materials science; Organic chemistry; Nanotechnology; Nanoparticle; Biochemistry","score_opus":0.2725304800403541,"score_gpt":0.4987172540220918,"score_spread":0.22618677398173775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605780223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872708,0.00065277575,0.007913619,0.001783224,0.0013376611,0.0007514935,0.00006271046,0.000009589866,0.00021815166],"genre_scores_gemma":[0.99437654,0.00011021909,0.0045216344,0.00057988445,0.00032539357,0.000022006532,0.000019637093,0.000019363713,0.000025330468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99690366,0.00060238043,0.0011678928,0.00018751103,0.00084716803,0.00029139177],"domain_scores_gemma":[0.99487257,0.00077117246,0.0016172301,0.00023402825,0.002240847,0.0002641311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004580111,0.000190755,0.00040955693,0.00019306841,0.0002725791,0.00001951076,0.00043951574,0.00022271526,0.00023325569],"category_scores_gemma":[0.00090858474,0.00017699231,0.00026130406,0.00008305295,0.00042593654,0.00055008347,0.00004766258,0.0005341483,0.0000028300678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026583527,0.0007671236,0.02991878,0.0005477319,0.00057548896,0.000005971339,0.00063737726,0.012952121,0.8667569,0.0017866812,0.0011177715,0.0822757],"study_design_scores_gemma":[0.0068752104,0.0002125655,0.006329567,0.0001238524,0.0015919079,0.000006220093,0.000044420638,0.26304165,0.7125725,0.0065274625,0.0025294719,0.00014517369],"about_ca_topic_score_codex":0.000009887659,"about_ca_topic_score_gemma":0.0000067111364,"teacher_disagreement_score":0.25008953,"about_ca_system_score_codex":0.0001956725,"about_ca_system_score_gemma":0.00050222815,"threshold_uncertainty_score":0.7217537},"labels":[],"label_agreement":null},{"id":"W2895673871","doi":"10.1007/s40005-018-0408-2","title":"Orally disintegrating dosage forms","year":2018,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosage form; Active ingredient; Immediate release; Pharmacology; Patient compliance; Drug; Chemistry; Medicine","score_opus":0.21208761167724247,"score_gpt":0.4768319720973726,"score_spread":0.26474436042013016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895673871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768197,0.0004874591,0.0029339665,0.0031559884,0.0036414072,0.00026586239,0.000015981848,0.0000668014,0.012612833],"genre_scores_gemma":[0.9910067,0.000073361036,0.0013232527,0.0050893044,0.0020404893,0.000004292243,0.0000068605464,0.000021869555,0.00043387542],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732524,0.00060390675,0.00102448,0.00019885678,0.00042141238,0.00042609463],"domain_scores_gemma":[0.99754584,0.00040516193,0.00061047706,0.00013757928,0.00065392803,0.000647003],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026045765,0.00022485157,0.00035933606,0.00018675262,0.00030778497,0.00007292564,0.00035998292,0.0002956857,0.0012470387],"category_scores_gemma":[0.0005257974,0.00017612948,0.00019213946,0.00037910472,0.0007400983,0.000704261,0.000062782026,0.0011860045,0.00028346333],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002289923,0.0008252459,0.053368255,0.00033256045,0.0008977496,0.00031538913,0.007530543,0.00047903098,0.7199373,0.04270454,0.06535552,0.10596394],"study_design_scores_gemma":[0.0046368614,0.0013754896,0.0036814471,0.0002463355,0.0005732033,0.00079161033,0.0008709022,0.038176913,0.46443298,0.014925449,0.46965703,0.0006317693],"about_ca_topic_score_codex":0.000007730427,"about_ca_topic_score_gemma":0.000009225871,"teacher_disagreement_score":0.40430152,"about_ca_system_score_codex":0.0001297016,"about_ca_system_score_gemma":0.00020239377,"threshold_uncertainty_score":0.999666},"labels":[],"label_agreement":null},{"id":"W4289516766","doi":"10.1007/s40005-022-00582-y","title":"Development of a patient-centric formulation of tegoprazan, a novel potassium-competitive acid blocker, using modified-release drug-coated pellets","year":2022,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novelis (Canada)","funders":"Ministry of Science and ICT, South Korea","keywords":"Pellets; Capsule; Enteric coating; Coating; Materials science; Dissolution; Particle size; Dissolution testing; Chemistry; Chemical engineering; Nuclear chemistry; Chromatography; Polymer; Ethyl cellulose; Nanotechnology; Composite material; Organic chemistry","score_opus":0.061149302163599706,"score_gpt":0.32588396098121775,"score_spread":0.26473465881761804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289516766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797124,0.00017837975,0.0010676517,0.00013438692,0.00017729776,0.00035594995,0.000020409629,0.000008034122,0.000086659464],"genre_scores_gemma":[0.9817692,0.0000058250876,0.017959686,0.00014903223,0.000037060396,0.000005938875,0.000039087914,0.000017443626,0.000016694501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976337,0.000106585365,0.0010318424,0.00014551776,0.0008668795,0.00021545024],"domain_scores_gemma":[0.998097,0.00006302487,0.0009786838,0.00009212953,0.0004647965,0.00030436396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003644263,0.0001625372,0.0003869001,0.00037193418,0.000119874145,0.0000066214243,0.0000821238,0.00004306279,0.00013842042],"category_scores_gemma":[0.00015221334,0.00014062313,0.00014076188,0.00048074036,0.000075229065,0.0001592946,0.00006912475,0.000355184,0.0000013774445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091651955,0.002093586,0.026338786,0.00022394516,0.00048918475,0.00017908156,0.0027727545,0.0025049292,0.95920163,0.0006369812,0.00005062811,0.0045919963],"study_design_scores_gemma":[0.0071490845,0.0005854272,0.0106993755,0.00018208736,0.00066439476,0.00032727417,0.00051116484,0.03262491,0.94681144,0.00014830928,0.00019251404,0.00010402407],"about_ca_topic_score_codex":0.0000052307732,"about_ca_topic_score_gemma":2.9024164e-7,"teacher_disagreement_score":0.030119983,"about_ca_system_score_codex":0.0003420357,"about_ca_system_score_gemma":0.00057042897,"threshold_uncertainty_score":0.5734445},"labels":[],"label_agreement":null},{"id":"W4406783172","doi":"10.1007/s40005-024-00718-2","title":"Thioester platform to develop potential nanomedicines for breast cancer therapy","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Cancer therapy; Thioester; Medicine; Cancer; Computational biology; Internal medicine; Chemistry; Biology; Biochemistry","score_opus":0.04277358785032104,"score_gpt":0.3668777419741542,"score_spread":0.32410415412383314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406783172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144484,0.00072959275,0.009338145,0.0074537736,0.0007786167,0.00016954888,0.000018074363,0.0000028601087,0.000064549815],"genre_scores_gemma":[0.98792523,0.0005125098,0.0012489834,0.009189456,0.00068782776,0.000014835402,0.000010162707,0.0000075740645,0.0004033981],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999335,0.000020414693,0.00029209568,0.00011231835,0.00010720844,0.00013295747],"domain_scores_gemma":[0.9990983,0.0000137923535,0.00009472606,0.000063405976,0.00061179866,0.00011796866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023308267,0.000090954076,0.00012047069,0.000084833286,0.000046652935,0.000023278773,0.0001385183,0.00007900413,0.000030225987],"category_scores_gemma":[0.00006894949,0.00006869582,0.00006169795,0.00014110439,0.00005157525,0.000012852562,0.000028323851,0.00008427257,0.0000017518176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060685945,0.00002354794,0.0018973959,0.00001885814,0.00010649274,0.0000012688149,0.000049945866,0.00017505759,0.95151913,0.0000857413,0.01668873,0.028826965],"study_design_scores_gemma":[0.0014303845,0.00031331112,0.0152222635,0.0001150001,0.00005732575,0.000034637815,0.00006186932,0.00038348098,0.9380407,0.0005078263,0.043712787,0.00012041089],"about_ca_topic_score_codex":0.0000028977063,"about_ca_topic_score_gemma":0.0000029913797,"teacher_disagreement_score":0.028706554,"about_ca_system_score_codex":0.000022893068,"about_ca_system_score_gemma":0.0002736175,"threshold_uncertainty_score":0.28013343},"labels":[],"label_agreement":null},{"id":"W766751705","doi":"","title":"Conducts and Analysis of Bioavailability & Bioequivalence Studies in Canada -Part A: Oral Dosage Formulations Used for Systemic Effects-","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Bioavailability; Pharmacology; Dosage form; Medicine","score_opus":0.57195039080542,"score_gpt":0.5044450307002595,"score_spread":0.0675053601051605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W766751705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901815,0.0036311846,0.00038489985,0.0048684743,0.0002502048,0.0005038773,0.00016200595,0.000004055797,0.000013774049],"genre_scores_gemma":[0.9966248,0.00041722,0.0015289419,0.0012802465,0.00008260326,0.000021730018,0.000013602568,0.000008196706,0.000022613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955269,0.0003517885,0.0035598418,0.00022417562,0.0001258442,0.00021142486],"domain_scores_gemma":[0.9953454,0.002433413,0.0016880635,0.0001497125,0.0001910539,0.00019233952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008845678,0.0001247226,0.0011123007,0.00041622066,0.00006743563,0.000018448805,0.00011944029,0.00006290198,0.00008530782],"category_scores_gemma":[0.002894888,0.00013333002,0.00010963555,0.0005610517,0.00018488067,0.00048006538,0.0000118816315,0.00014318283,0.0000040762584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011592294,0.0001324544,0.9615651,0.0034957312,0.0019438426,0.000005869607,0.0037239054,0.0065062866,0.0014470024,0.016767424,0.0033645213,0.00093198795],"study_design_scores_gemma":[0.010012463,0.0006536618,0.47599494,0.0017726505,0.0022487438,0.00007536597,0.0036035888,0.45443633,0.0055597373,0.036697,0.0077693895,0.0011761325],"about_ca_topic_score_codex":0.020845281,"about_ca_topic_score_gemma":0.025565058,"teacher_disagreement_score":0.4855701,"about_ca_system_score_codex":0.0009903348,"about_ca_system_score_gemma":0.0005090523,"threshold_uncertainty_score":0.9922158},"labels":[],"label_agreement":null}]}